Anzeige
Mehr »
Login
Mittwoch, 28.10.2020 Börsentäglich über 12.000 News von 649 internationalen Medien
Unglaublicher News-Flow!!! Diese Firma liefert einfach gewaltig ab!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PKMZ ISIN: US6700024010 Ticker-Symbol: NVV1 
Tradegate
28.10.20
18:09 Uhr
69,70 Euro
-5,92
-7,83 %
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NOVAVAX INC Chart 1 Jahr
5-Tage-Chart
NOVAVAX INC 5-Tage-Chart
RealtimeGeldBriefZeit
70,0170,7218:02
69,6370,4018:11

Aktuelle News zur NOVAVAX Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17:22Why Coronavirus Vaccine Stocks Moderna, Novavax, and Inovio Are Sinking Today23
16:19Novavax Stock Might Actually Win This War of Attrition6
15:42Manufacturing delays push Novavax's COVID-19 vax trial to end of November6
NOVAVAX Aktie jetzt für 0€ handeln
15:29Biotech Stock Roundup: GILD's Veklury Approved, NVAX Provides Vaccine Update & More18
13:19Vaccine Hopeful Novavax Could Be Worth a Shot12
06:57AUPH Initiates VOCOVID Trial, KALA Gets FDA Nod, NVAX Expands COVID-19 Vaccine Study Size In UK184OTTAWA (dpa-AFX) - Today's Daily Dose brings you news about Aurinia initiating a trial of its lead candidate Voclosporin in kidney transplant recipients with COVID-19, Exact Sciences' Q3 financial...
► Artikel lesen
DiUPDATE 3-Novavax delays U.S. trial of COVID-19 vaccine to November19
DiNovavax to start US Phase 3 COVID-19 vaccine trial next month15
DiWhy Novavax Stock Is Moving Higher Today9
DiNovavax Rallies On Phase 3 Coronavirus Study Updates, Imminent Phase 2 Readout6
DiModerna, Novavax Advance Covid-19 Vaccine Candidates37
DiNovavax To Begin Late-stage COVID-19 Vaccine Trial In U.S. And Mexico By November-end278WASHINGTON (dpa-AFX) - Novavax Inc. (NVAX) said Tuesday that it will begin a late-stage trial of its COVID-19 vaccine in the United States and Mexico by the end of November. Previously, it...
► Artikel lesen
DiNovavax Shares Jump After Coronavirus Vaccine Trial Update10
DiUPDATE 2-Novavax delays U.S. trial of COVID-19 vaccine candidate to November5
DiNovavax expands late-stage UK trial for COVID-19 vaccine candidate to 15,000 volunteers1
DiNovavax's stock rises 3% as it announces plans to share Phase 2 vaccine data this week10
DiNovavax expects data from UK trial of coronavirus vaccine in first-quarter 202113
DiNovavax, Inc.: Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update7755,500 volunteers enrolled to date in pivotal Phase 3 clinical trial in the U.K. Study expanded to 15,000 participantsFull enrollment expected by end of NovemberEvent-driven interim data expected...
► Artikel lesen
SaBetter Coronavirus Stock: Moderna or Novavax?116
FrCan Novavax Stock Overcome Growing Vaccine Distrust?40
Seite:  Weiter >>
697 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
57,28,113